Unresectable Primary Enteric‐Type Thymic Adenocarcinoma Treated With <scp>FOLFOX</scp> Chemotherapy: A Case Report

We report the first case of primary enteric-type thymic adenocarcinoma treated at an Australian institution, and the first published case using FOLFOX as frontline systemic therapy in a patient with unresectable primary enteric-type thymic adenocarcinoma. Noting the close molecular resemblance between enteric-type thymic adenocarcinoma and gastrointestinal malignancies, chemotherapy regimens commonly used in the treatment of gastrointestinal cancer may offer a more effective option than standard frontline therapies used in thymic carcinomas for the management of enteric-type thymic adenocarcinoma.